Richard Chesworth - Net Worth and Insider Trading

Richard Chesworth Net Worth

The estimated net worth of Richard Chesworth is at least $0 dollars as of 2024-09-20. Richard Chesworth is the Chief Scientific Officer of Kymera Therapeutics Inc and owns about 0 shares of Kymera Therapeutics Inc (KYMR) stock worth over $0. Details can be seen in Richard Chesworth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Chesworth has not made any transactions after 2021-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard Chesworth

To

Richard Chesworth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Chesworth owns 1 companies in total, including Kymera Therapeutics Inc (KYMR) .

Click here to see the complete history of Richard Chesworth’s form 4 insider trades.

Insider Ownership Summary of Richard Chesworth

Ticker Comapny Transaction Date Type of Owner
KYMR Kymera Therapeutics Inc 2021-08-27 Chief Scientific Officer

Richard Chesworth Latest Holdings Summary

Richard Chesworth currently owns a total of 1 stock. Richard Chesworth owns 0 shares of Kymera Therapeutics Inc (KYMR) as of August 27, 2021, with a value of $0.

Latest Holdings of Richard Chesworth

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KYMR Kymera Therapeutics Inc 2021-08-27 0 48.56 0

Holding Weightings of Richard Chesworth


Richard Chesworth Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Chesworth has made a total of 2 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 33,779 shares on August 27, 2021, which brought Richard Chesworth around $2 Million.

Insider Trading History of Richard Chesworth

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Chesworth Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Chesworth Ownership Network

Ownership Network List of Richard Chesworth

No Data

Ownership Network Relation of Richard Chesworth

Insider Network Chart

Richard Chesworth Owned Company Details

What does Kymera Therapeutics Inc do?

Who are the key executives at Kymera Therapeutics Inc?

Richard Chesworth is the Chief Scientific Officer of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .

Kymera Therapeutics Inc (KYMR) Insider Trades Summary

Over the past 18 months, Richard Chesworth made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .

In summary, during the past 3 months, insiders sold 512,060 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 512,059 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kymera Therapeutics Inc Insider Transactions

No Available Data

Richard Chesworth Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Chesworth. You might contact Richard Chesworth via mailing address: C/o Kymera Therapeutics, Inc., 200 Arsenal Yards, Suite 230, Watertown Ma 02472.

Discussions on Richard Chesworth

No discussions yet.